Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression

Journal of Neurochemistry

Volumn 111, Issue 3, 2009, Pages 647-655

  Tao, Tao ^a,b   Ji, Yuhong ^b   Cheng, Chun ^b   Yang, Huiguang ^b   Liu, Haiou ^b   Sun, Linlin ^b   Qin, Yongwei ^b   Yang, Junling ^a   Wang, Huiming ^a   Shen, Aiguo ^a  

^a NANTONG UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

Cyclin D1; Extracellular signal regulated kinase 1 2; Schwann cell; SSeCKS; Tumor necrosis factor alpha

Indexed keywords

CYCLIN D1; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; SRC SUPPRESSED PROTEIN KINASE C SUBSTRATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE ARREST; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE TRANSLOCATION; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SCHWANN CELL;

A KINASE ANCHOR PROTEINS; ANIMALS; ANIMALS, NEWBORN; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; IMMUNOPRECIPITATION; MITOGEN-ACTIVATED PROTEIN KINASE 3; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA, SMALL INTERFERING; SCHWANN CELLS; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 70349931329     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06346.x     Document Type: Article

References (49)

1. Assoian R. K. (1997) Anchorage-dependent cell cycle progression. J Cell Biol. 136, 1 4.
2. Atanasoski S., Shumas S., Dickson C., Scherer S. S. Suter U. (2001) Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol. Cell. Neurosci. 18, 581 592.
3. Baldin V., Lukas J., Marcote M. J., Pagano M. Draetta G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812 821.
4. Bonetti B., Valdo P., Stegagno C., Tanel R., Zanusso G. L., Ramarli D., Fiorini E., Turazzi S., Carner M. Moretto G. (2000) Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J. Neuropathol. Exp. Neurol. 59, 74 84.
5. Boyle K., Azari M. F., Cheema S. S. Petratos S. (2005) TNFalpha mediates Schwann cell death by upregulating p75NTR expression without sustained activation of NFkappaB. Neurobiol. Dis. 20, 412 427.
6. Brockes J. P., Fields K. L. Raff M. C. (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165, 105 118.
7. Byun H. S., Park K. A., Won M. et al. (2006) Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C. Mol. Pharmacol. 70, 1099 1108.
8. Camus A., Mesbah K., Rallu M., Babinet C. Barra J. (2001) Gene trap insertion reveals two open reading frames in the mouse SSeCKS gene: the form predominantly detected in the nervous system is suppressed by the insertion while the other, specific of the testis, remains expressed. Mech. Dev. 105, 79 91.
9. Chandross K. J., Spray D. C., Cohen R. I., Kumar N. M., Kremer M., Dermietzel R. Kessler J. A. (1996) TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol. Cell. Neurosci. 7, 479 500.
10. Chen L., Qin J., Cheng C., Niu S., Liu Y., Shi S., Liu H. Shen A. (2008) Spatiotemporal expression of SSeCKS in injured rat sciatic nerve. Anat. Rec. (Hoboken) 291, 527 537.
11. Dhanasekaran S. M., Barrette T. R., Ghosh D., Shah R., Varambally S., Kurachi K., Pienta K. J., Rubin M. A. Chinnaiyan A. M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822 826.
12. Fernandez-Valle C., Bunge R. P. Bunge M. B. (1995) Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J. Neurocytol. 24, 667 679.
13. Gelman I. H. (2002) The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci. 7, d1782 d1797.
14. Gelman I. H., Lee K., Tombler E., Gordon R. Lin X. (1998) Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS. Cell Motil. Cytoskeleton 41, 1 17.
15. Hartung H. P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J. Toyka K. V. (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197 210.
16. Kamiya H., Nakamura J., Hamada Y., Nakashima E., Naruse K., Kato K., Yasuda Y. Hotta N. (2003) Polyol pathway and protein kinase C activity of rat Schwannoma cells. Diabetes Metab. Res. Rev. 19, 131 139.
17. Kim H. A., Pomeroy S. L., Whoriskey W., Pawlitzky I., Benowitz L. I., Sicinski P., Stiles C. D. Roberts T. M. (2000) A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron 26, 405 416.
18. Kury P., Koller H., Hamacher M., Cornely C., Hasse B. Muller H. W. (2003) Cyclic AMP and tumor necrosis factor-alpha regulate CXCR4 gene expression in Schwann cells. Mol. Cell. Neurosci. 24, 1 9.
19. Lavoie J. N., Rivard N., L'Allemain G. Pouyssegur J. (1996) A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res. 2, 49 58.
20. Lew J. Wang J. H. (1995) Neuronal cdc2-like kinase. Trends Biochem. Sci. 20, 33 37.
21. Lin X. Gelman I. H. (1997) Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res. 57, 2304 2312.
22. Lin X. Gelman I. H. (2002) Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Biochem. Biophys. Res. Commun. 290, 1368 1375.
23. Lin X., Nelson P. J., Frankfort B., Tombler E., Johnson R. Gelman I. H. (1995) Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol. Cell. Biol. 15, 2754 2762.
24. Lin X., Tombler E., Nelson P. J., Ross M. Gelman I. H. (1996) A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J. Biol. Chem. 271, 28430 28438.
25. Lin X., Nelson P. Gelman I. H. (2000) SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1) - >S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol. Cell. Biol. 20, 7259 7272.
26. Liu Y., Gao L. Gelman I. H. (2006) SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC cancer 6, 105.
27. Lu M. O., Duan R. S., Quezada H. C., Chen Z. G., Mix E., Jin T., Yang X., Ljunggren H. G. Zhu J. (2007) Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice. J. Neuroimmunol. 186, 19 26.
28. Lung H. L., Shan S. W., Tsang D. Leung K. N. (2005) Tumor necrosis factor-alpha mediates the proliferation of rat C6 glioma cells via beta-adrenergic receptors. J. Neuroimmunol. 166, 102 112.
29. Monje P. V., Bartlett Bunge M. Wood P. M. (2006) Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells. Glia 53, 649 659.
30. Nauert J. B., Klauck T. M., Langeberg L. K. Scott J. D. (1997) Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr. Biol. 7, 52 62.
31. Nelson P. J. Gelman I. H. (1997) Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response. Mol. Cell. Biochem. 175, 233 241.
32. Okuda H., Saitoh K., Hirai S., Iwai K., Takaki Y., Baba M., Minato N., Ohno S. Shuin T. (2001) The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J. Biol. Chem. 276, 43611 43617.
33. Perou C. M., Sorlie T., Eisen M. B. et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747 752.
34. Pines J. (1991) Cyclins: wheels within wheels. Cell Growth Differ. 2, 305 310.
35. Pines J. Hunter T. (1991) Cyclin-dependent kinases: a new cell cycle motif? Trends Cell Biol. 1, 117 121.
36. Porter S., Clark M. B., Glaser L. Bunge R. P. (1986) Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J. Neurosci. 6, 3070 3078.
37. Scarpini E., Conti G. C., Bussini S., Clerici R., Siglienti I., Piccio L., De Pol A., Baron P. L. Scarlato G. (1999) Human schwann cell proliferation and IL-6 production following TNF-alpha stimulation in vitro. Ann. NY Acad. Sci. 883, 520 522.
38. Schafers M., Svensson C. I., Sommer C. Sorkin L. S. (2003) Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 2517 2521.
39. Streb J. W., Kitchen C. M., Gelman I. H. Miano J. M. (2004) Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J. Biol. Chem. 279, 56014 56023.
40. Sun L. L., Cheng C., Liu H. O., Xiao F., Qin J., Shao X. Y. Shen A. G. (2007a) Changes of Src-suppressed C kinase substrate expression in cytokine induced reactive C6 glioma cells. Neurosci. Bull. 23, 101 106.
41. Sun L. L., Cheng C., Liu H. O., Shen C. C., Xiao F., Qin J., Yang J. L. Shen A. G. (2007b) Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-alpha biosynthesis in rat astrocytes. J. Mol. Neurosci. 32, 16 24.
42. Taylor J. M. Pollard J. D. (2007) Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation. J. Neuroimmunol. 183, 118 124.
43. Wagner R. Myers R. R. (1996) Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73, 625 629.
44. Walikonis R. S. Poduslo J. F. (1998) Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries. J. Biol. Chem. 273, 9070 9077.
45. Xia W., Unger P., Miller L., Nelson J. Gelman I. H. (2001) The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res. 61, 5644 5651.
46. Yamamoto M., Tamakawa S., Yoshie M., Yaginuma Y. Ogawa K. (2006) Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Mol. Carcinog. 45, 901 913.
47. Yan M., Xia C., Cheng C., Shao X., Niu S., Liu H. Shen A. (2007) The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes. Brain Res. 1184, 28 37. (Pubitemid 350160591)
48. Yoon D. K., Jeong C. H., Jun H. O. et al. (2007) AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett. 254, 111 118.
49. Yu C., Takeda M. Soliven B. (2000) Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage. J. Neuroimmunol. 108, 2 10.